Adrian is a long-standing member of ARCS having contributed to our professional organisation for many decades, including as a Board Member for 10 years, CEO for 6 years, interest area member and head, clinical research fellow, speaker, chair and was awarded ARCS life membership in 2009. Adrian has also worked in project and line management for clinical research and regulatory affairs at Roche and served as Head of Prescription Medicines Branch and Senior Executive Service, TGA 2016-21, bringing in many reforms, streamlining, 6 new approval pathways and enacting international regulatory collaborations. During this time his branch brought forward many approvals, including the first Covid-19 medicines and the first gene therapies as well as the first new medicine joint evaluations and approvals. He now teaches, consults and advises for his own company, CR Consult Pty Ltd.

Dr Bridget Gilmour-Walsh is the Principal Legal and Policy Adviser/First Assistant Secretary at the Therapeutic Goods Administration, a position which she has held since 2022. She has been leading the development of the Australian Government’s vaping reforms, working closely with a range of stakeholders including medical practitioners and health peak organisations. Bridget has 25 years of experience as a public sector legal adviser, including 18 years at the Australian Government Solicitor.

Nicole started her career in finance and has been the CFO and head of corporate services for a number of organisations in both the private and public sectors. Nicole has worked with the Therapeutic Goods Administration for a number of years now and is currently the Assistant Secretary of the Vaping Implementation and Enforcement Branch. This branch provides program and project support for the reforms to the regulation of vaping products and is responsible for enforcement of the associated laws under the Commonwealth Therapeutic Goods Act 1989.

Meredith Claremont is the Executive Director for the Centre for Population Health, which leads the statewide approach to modifiable risk factors of obesity, physical activity, nutrition, smoking and vaping, viral hepatitis and sexually transmitted infections. The Centre’s work includes leading tobacco and e-cigarette enforcement in NSW. Meredith has thirty years of experience in public policy across the health, justice, environment and central agencies of government. She has a strong commitment to equity and is known for her expertise in significant and sensitive public policy areas. She collaborates across sectors and with experts to drive strategic reform and deliver outcomes with a focus on population and community health and wellbeing.